Koers Charles River Laboratories International, Inc. Mexican S.E.
Aandelen
CRL *
US1598641074
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4.049 MXN | +1,84% | -.--% | +3,57% |
Omzet 2024 * | 4,22 mld. 70,45 mld. 3,89 mld. | Omzet 2025 * | 4,53 mld. 75,6 mld. 4,17 mld. | Marktkapitalisatie | 11,21 mld. 187 mld. 10,33 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 406 mln. 6,78 mld. 374 mln. | Nettowinst (verlies) 2025 * | 513 mln. 8,56 mld. 473 mln. | EV/omzet 2024 * | 3,12 x |
Nettoschuld 2024 * | 1,94 mld. 32,46 mld. 1,79 mld. | Nettoschuld 2025 * | 1,46 mld. 24,33 mld. 1,34 mld. | EV/omzet 2025 * | 2,8 x |
K/w-verhouding 2024 * |
27,5
x | K/w-verhouding 2025 * |
22,3
x | Werknemers | 21.100 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,93% |
Recentste transcriptie over Charles River Laboratories International, Inc.
1 dag | +1,84% | ||
1 maand | +1,84% | ||
3 maanden | +3,57% | ||
6 maanden | +24,62% | ||
Lopend jaar | +3,57% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Foster
CEO | Chief Executive Officer | 73 | 01-01-76 |
Flavia Pease
DFI | Director of Finance/CFO | 51 | 25-04-22 |
Birgit Girshick
COO | Chief Operating Officer | 54 | 01-04-89 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
George Massaro
BRD | Director/Board Member | 76 | 01-01-03 |
Virginia Wilson
BRD | Director/Board Member | 68 | 01-10-19 |
Robert Bertolini
BRD | Director/Board Member | 61 | 25-01-11 |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+69,37% | 62,86 mld. | |
-0,89% | 41,38 mld. | |
+45,66% | 40,38 mld. | |
-10,72% | 27,64 mld. | |
+14,40% | 26,46 mld. | |
-22,21% | 18,9 mld. | |
+4,54% | 12,67 mld. | |
+24,08% | 12,27 mld. | |
+28,21% | 12,07 mld. |